Why the Conventional Treatment of Scleroderma is Flawed
Posted Feb 08 2010 12:00am
Scleroderma is a relatively common and often debilitating condition. In light of that, one might reasonably assume that scientists and medical professionals would be able to devise a successful method for the treatment of the disorder. Unfortunately, that's not the case. The conventional means by which the medical profession addresses Scleroderma merely masks symptoms while ignoring its underlying causes. Ironically, the most frequently prescribed treatments may actually contribute to a worsening of the condition.
The Conventional Treatment of Scleroderma
The most common response to Scleroderma involves the use of medications. These include immunosuppressants like Mehotrexate and Cytoxan, no steroidal anti-inflammatory drugs (NSAIDs) and cortiosteroids. Doctors may recommend the use of antacids, medications to aid in breathing and blood pressure medications to aid in the treatment of some of Scleroderma's symptoms, as well.
A Symptom-Only Approach
Unforunately, the usual treatment of Scleroderma is focused exclusively on mitigating its symptoms. That is a perfectly reasonable way to provide patients with some degree of relief, but it does absolutely nothing to eliminate the root causes of the malady. Medicating symptoms away is akin to regularly changing bandages on an otherwise untreated open wound. It may make things seem a little better, but it isn't encouraging real healing.
The status quo subscribes to this method of treatment because the medical community maintains there is a lack of certainty regarding the core cause of Scleroderma. They note a potential genetic tendency toward the condition, but don't make claims regarding its triggers. However, there is growing evidence indicating that pathogenic nano bacteria are a major factor in the development of Scleroderma. The multiplication of the bacteria hardens and destroys skin cells while creating visible superficial Calcinosis, according to some researchers.
How the Treatment of Scleroderma Backfires
The ability of the body to respond to pathogenic nano bacteria is carefully tied to the way the body reacts to toxins in general. Those with overreactive systems find themselves at war with foreign toxins, encouraging more pathogenic bacteria growth while being unable to effectively combat the development.
Ironically, the very medications used to combat Scleroderma leads to the accumulation of toxins within the body. Defeating the symptoms also serves as a trigger for the disorder, according to this school of thought. This means that the normal treatment of Scleroderma is worse than ineffective--it's actually destructive. The "cure" actually encourages the disorder.
#1 Natural 6 Step Method Relieves Most Scleroderma Symptoms In Weeks http://www.scleroderma-cure.com. The Only Alternative To Drugs.